<?xml version="1.0" encoding="UTF-8"?>
<p>Considering CE treatment, in cases where the cysts are small and inactive, compounds and derivatives of benzimidazole are used as the first-choice treatments, while surgery is the preferred treatment for large and active cysts [
 <xref rid="B5-molecules-26-00888" ref-type="bibr">5</xref>,
 <xref rid="B6-molecules-26-00888" ref-type="bibr">6</xref>]. The rupture of a cyst or leakage of cyst contents (protoscoleces), which leads to secondary infection or the involvement of nearby organs, is the main concern during hydatid cyst surgery [
 <xref rid="B7-molecules-26-00888" ref-type="bibr">7</xref>]. To minimize these risks, various chemical protoscolicidal agents such as hypertonic saline (20%), silver nitrate, and formalin are used [
 <xref rid="B8-molecules-26-00888" ref-type="bibr">8</xref>]. However, recent investigations have reported that these agents are not completely safe and have various adverse side effects including biliary fibrosis, hepatic necrosis, and cirrhosis [
 <xref rid="B9-molecules-26-00888" ref-type="bibr">9</xref>]. For this reason, finding and discovering new scolicidal drugs with high efficiency and minimal toxicity and side effects is a priority for researchers.
</p>
